 | • レポートコード：QYR9ST01860 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界の医薬品有効成分（API）市場について調査・分析し、以下の構成でお届け致します。医薬品有効成分（API）の種類別には、合成、バイオテクノロジーに、用途別には、診断研究所、研究及び学術研究所、製薬及びバイオテクノロジー企業に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別医薬品有効成分（API）売上データ ・地域別医薬品有効成分（API）市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別医薬品有効成分（API）市場規模：合成、バイオテクノロジー ・用途別医薬品有効成分（API）市場規模：診断研究所、研究及び学術研究所、製薬及びバイオテクノロジー企業 ・主要メーカーの企業情報：Merck、Novartis、Pfizer、Roche、Sun Pharmaceutical Industries、Teva Pharmaceutical Industries、Abbott Laboratories、Emcure Pharmaceuticals、Ipca Laboratories、Johnson Matthey、Guilin Pharmaceutical、Johnson & Johnson、Lonza Group ・医薬品有効成分（API）の市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
The Active Pharmaceutical Ingredient (API) is the part of any drug that produces its effects. Some drugs, such as combination therapies, have multiple active ingredients to treat different symptoms or act in different ways.Production of APIs has traditionally been done by the pharmaceutical companies themselves in their home countries. But in recent years many corporations have opted to send manufacturing overseas to cut costs.
This has caused significant changes to how these drugs are regulated, with more rigorous guidelines and inspections put into place.
The global Active Pharmaceutical Ingredients market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Active Pharmaceutical Ingredients market based on company, product type, end user and key regions.
This report studies the global market size of Active Pharmaceutical Ingredients in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Active Pharmaceutical Ingredients in these regions.
This research report categorizes the global Active Pharmaceutical Ingredients market by top players/brands, region, type and end user. This report also studies the global Active Pharmaceutical Ingredients market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Merck
Novartis
Pfizer
Roche
Sun Pharmaceutical Industries
Teva Pharmaceutical Industries
Abbott Laboratories
Emcure Pharmaceuticals
Ipca Laboratories
Johnson Matthey
Guilin Pharmaceutical
Johnson & Johnson
Lonza Group
Market size by Product
Synthetic
Biotech
Market size by End User
Diagnostic Laboratories
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Active Pharmaceutical Ingredients market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Active Pharmaceutical Ingredients market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Active Pharmaceutical Ingredients companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Active Pharmaceutical Ingredients submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Active Pharmaceutical Ingredients are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Active Pharmaceutical Ingredients market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Active Pharmaceutical Ingredients Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Active Pharmaceutical Ingredients Market Size Growth Rate by Product
1.4.2 Synthetic
1.4.3 Biotech
1.5 Market by End User
1.5.1 Global Active Pharmaceutical Ingredients Market Size Growth Rate by End User
1.5.2 Diagnostic Laboratories
1.5.3 Research & Academic Laboratories
1.5.4 Pharmaceutical & Biotechnology Companies
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Active Pharmaceutical Ingredients Market Size
2.1.1 Global Active Pharmaceutical Ingredients Revenue 2014-2025
2.1.2 Global Active Pharmaceutical Ingredients Sales 2014-2025
2.2 Active Pharmaceutical Ingredients Growth Rate by Regions
2.2.1 Global Active Pharmaceutical Ingredients Sales by Regions
2.2.2 Global Active Pharmaceutical Ingredients Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Active Pharmaceutical Ingredients Sales by Manufacturers
3.1.1 Active Pharmaceutical Ingredients Sales by Manufacturers
3.1.2 Active Pharmaceutical Ingredients Sales Market Share by Manufacturers
3.1.3 Global Active Pharmaceutical Ingredients Market Concentration Ratio (CR5 and HHI)
3.2 Active Pharmaceutical Ingredients Revenue by Manufacturers
3.2.1 Active Pharmaceutical Ingredients Revenue by Manufacturers (2014-2019)
3.2.2 Active Pharmaceutical Ingredients Revenue Share by Manufacturers (2014-2019)
3.3 Active Pharmaceutical Ingredients Price by Manufacturers
3.4 Active Pharmaceutical Ingredients Manufacturing Base Distribution, Product Types
3.4.1 Active Pharmaceutical Ingredients Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Active Pharmaceutical Ingredients Product Type
3.4.3 Date of International Manufacturers Enter into Active Pharmaceutical Ingredients Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Active Pharmaceutical Ingredients Sales by Product
4.2 Global Active Pharmaceutical Ingredients Revenue by Product
4.3 Active Pharmaceutical Ingredients Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Active Pharmaceutical Ingredients Breakdown Data by End User
6 North America
6.1 North America Active Pharmaceutical Ingredients by Countries
6.1.1 North America Active Pharmaceutical Ingredients Sales by Countries
6.1.2 North America Active Pharmaceutical Ingredients Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Active Pharmaceutical Ingredients by Product
6.3 North America Active Pharmaceutical Ingredients by End User
7 Europe
7.1 Europe Active Pharmaceutical Ingredients by Countries
7.1.1 Europe Active Pharmaceutical Ingredients Sales by Countries
7.1.2 Europe Active Pharmaceutical Ingredients Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Active Pharmaceutical Ingredients by Product
7.3 Europe Active Pharmaceutical Ingredients by End User
8 Asia Pacific
8.1 Asia Pacific Active Pharmaceutical Ingredients by Countries
8.1.1 Asia Pacific Active Pharmaceutical Ingredients Sales by Countries
8.1.2 Asia Pacific Active Pharmaceutical Ingredients Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Active Pharmaceutical Ingredients by Product
8.3 Asia Pacific Active Pharmaceutical Ingredients by End User
9 Central & South America
9.1 Central & South America Active Pharmaceutical Ingredients by Countries
9.1.1 Central & South America Active Pharmaceutical Ingredients Sales by Countries
9.1.2 Central & South America Active Pharmaceutical Ingredients Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Active Pharmaceutical Ingredients by Product
9.3 Central & South America Active Pharmaceutical Ingredients by End User
10 Middle East and Africa
10.1 Middle East and Africa Active Pharmaceutical Ingredients by Countries
10.1.1 Middle East and Africa Active Pharmaceutical Ingredients Sales by Countries
10.1.2 Middle East and Africa Active Pharmaceutical Ingredients Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Active Pharmaceutical Ingredients by Product
10.3 Middle East and Africa Active Pharmaceutical Ingredients by End User
11 Company Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Company Business Overview
11.1.3 Merck Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Merck Active Pharmaceutical Ingredients Products Offered
11.1.5 Merck Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Company Business Overview
11.2.3 Novartis Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Novartis Active Pharmaceutical Ingredients Products Offered
11.2.5 Novartis Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Company Business Overview
11.3.3 Pfizer Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Pfizer Active Pharmaceutical Ingredients Products Offered
11.3.5 Pfizer Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Company Business Overview
11.4.3 Roche Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Roche Active Pharmaceutical Ingredients Products Offered
11.4.5 Roche Recent Development
11.5 Sun Pharmaceutical Industries
11.5.1 Sun Pharmaceutical Industries Company Details
11.5.2 Company Business Overview
11.5.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients Products Offered
11.5.5 Sun Pharmaceutical Industries Recent Development
11.6 Teva Pharmaceutical Industries
11.6.1 Teva Pharmaceutical Industries Company Details
11.6.2 Company Business Overview
11.6.3 Teva Pharmaceutical Industries Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Teva Pharmaceutical Industries Active Pharmaceutical Ingredients Products Offered
11.6.5 Teva Pharmaceutical Industries Recent Development
11.7 Abbott Laboratories
11.7.1 Abbott Laboratories Company Details
11.7.2 Company Business Overview
11.7.3 Abbott Laboratories Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Abbott Laboratories Active Pharmaceutical Ingredients Products Offered
11.7.5 Abbott Laboratories Recent Development
11.8 Emcure Pharmaceuticals
11.8.1 Emcure Pharmaceuticals Company Details
11.8.2 Company Business Overview
11.8.3 Emcure Pharmaceuticals Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Emcure Pharmaceuticals Active Pharmaceutical Ingredients Products Offered
11.8.5 Emcure Pharmaceuticals Recent Development
11.9 Ipca Laboratories
11.9.1 Ipca Laboratories Company Details
11.9.2 Company Business Overview
11.9.3 Ipca Laboratories Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Ipca Laboratories Active Pharmaceutical Ingredients Products Offered
11.9.5 Ipca Laboratories Recent Development
11.10 Johnson Matthey
11.10.1 Johnson Matthey Company Details
11.10.2 Company Business Overview
11.10.3 Johnson Matthey Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Johnson Matthey Active Pharmaceutical Ingredients Products Offered
11.10.5 Johnson Matthey Recent Development
11.11 Guilin Pharmaceutical
11.12 Johnson & Johnson
11.13 Lonza Group
12 Future Forecast
12.1 Active Pharmaceutical Ingredients Market Forecast by Regions
12.1.1 Global Active Pharmaceutical Ingredients Sales Forecast by Regions 2019-2025
12.1.2 Global Active Pharmaceutical Ingredients Revenue Forecast by Regions 2019-2025
12.2 Active Pharmaceutical Ingredients Market Forecast by Product
12.2.1 Global Active Pharmaceutical Ingredients Sales Forecast by Product 2019-2025
12.2.2 Global Active Pharmaceutical Ingredients Revenue Forecast by Product 2019-2025
12.3 Active Pharmaceutical Ingredients Market Forecast by End User
12.4 North America Active Pharmaceutical Ingredients Forecast
12.5 Europe Active Pharmaceutical Ingredients Forecast
12.6 Asia Pacific Active Pharmaceutical Ingredients Forecast
12.7 Central & South America Active Pharmaceutical Ingredients Forecast
12.8 Middle East and Africa Active Pharmaceutical Ingredients Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Active Pharmaceutical Ingredients Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Active Pharmaceutical Ingredients Product Picture
Table Active Pharmaceutical Ingredients Market Segments
Table Key Manufacturers Active Pharmaceutical Ingredients Covered
Table Global Active Pharmaceutical Ingredients Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Active Pharmaceutical Ingredients Sales Market Share by Product 2014-2025
Figure Synthetic Product Picture
Table Major Manufacturers of Synthetic
Figure Biotech Product Picture
Table Major Manufacturers of Biotech
Table Global Active Pharmaceutical Ingredients Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Diagnostic Laboratories
Figure Research & Academic Laboratories
Figure Pharmaceutical & Biotechnology Companies
Figure Active Pharmaceutical Ingredients Report Years Considered
Figure Global Active Pharmaceutical Ingredients Market Size 2014-2025 (Million US$)
Figure Global Active Pharmaceutical Ingredients Sales 2014-2025 (K Units)
Table Global Active Pharmaceutical Ingredients Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Active Pharmaceutical Ingredients Sales by Regions 2014-2019 (K Units)
Table Global Active Pharmaceutical Ingredients Sales Market Share by Regions 2014-2019
Figure Global Active Pharmaceutical Ingredients Sales Market Share by Regions 2014-2019
Figure 2018 Global Active Pharmaceutical Ingredients Sales Market Share by Regions
Table Global Active Pharmaceutical Ingredients Revenue by Regions 2014-2019 (Million US$)
Table Global Active Pharmaceutical Ingredients Revenue Market Share by Regions 2014-2019
Figure Global Active Pharmaceutical Ingredients Revenue Market Share by Regions 2014-2019
Figure 2018 Global Active Pharmaceutical Ingredients Revenue Market Share by Regions
Table Global Active Pharmaceutical Ingredients Sales by Manufacturers (2014-2019) (K Units)
Table Global Active Pharmaceutical Ingredients Sales Share by Manufacturers (2014-2019)
Figure Global Active Pharmaceutical Ingredients Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Active Pharmaceutical Ingredients Revenue by Manufacturers (2014-2019) (Million USD)
Table Active Pharmaceutical Ingredients Revenue Share by Manufacturers (2014-2019)
Figure Active Pharmaceutical Ingredients Value Share by Manufacturers in 2018
Table Key Manufacturers Active Pharmaceutical Ingredients Price (2014-2019) (USD/Unit)
Table Active Pharmaceutical Ingredients Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Active Pharmaceutical Ingredients Product Type
Table Date of International Manufacturers Enter into Active Pharmaceutical Ingredients Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Active Pharmaceutical Ingredients Sales by Product (2014-2019) (K Units)
Table Global Active Pharmaceutical Ingredients Sales Share by Product (2014-2019)
Figure Global Active Pharmaceutical Ingredients Sales Market Share by Product (2014-2019)
Figure Global Active Pharmaceutical Ingredients Sales Market Share by Product in 2018
Table Global Active Pharmaceutical Ingredients Revenue by Product (2014-2019) (Million US$)
Table Global Active Pharmaceutical Ingredients Revenue Share by Product (2014-2019)
Figure Global Active Pharmaceutical Ingredients Revenue Market Share by Product (2014-2019)
Figure Global Active Pharmaceutical Ingredients Revenue Market Share by Product in 2018
Table Active Pharmaceutical Ingredients Price by Product 2014-2019 (USD/Unit)
Table Global Active Pharmaceutical Ingredients Sales by End User (2014-2019) (K Units)
Table Global Active Pharmaceutical Ingredients Sales Share by End User (2014-2019)
Figure Global Sales Active Pharmaceutical Ingredients Market Share by End User (2014-2019)
Figure Global Sales Active Pharmaceutical Ingredients Market Share by End User in 2018
Figure North America Active Pharmaceutical Ingredients Sales Growth Rate 2014-2019 (K Units)
Figure North America Active Pharmaceutical Ingredients Revenue Growth Rate 2014-2019 (Million US$)
Table North America Active Pharmaceutical Ingredients Sales by Countries (2014-2019) (K Units)
Table North America Active Pharmaceutical Ingredients Sales Market Share by Countries (2014-2019)
Figure 2018 North America Active Pharmaceutical Ingredients Sales Market Share by Countries
Table North America Active Pharmaceutical Ingredients Revenue by Countries (2014-2019) (Million US$)
Table North America Active Pharmaceutical Ingredients Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Active Pharmaceutical Ingredients Revenue Market Share by Countries
Figure United States Active Pharmaceutical Ingredients Sales Growth Rate (2014-2019) (K Units)
Figure United States Active Pharmaceutical Ingredients Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Active Pharmaceutical Ingredients Sales Growth Rate (2014-2019) (K Units)
Figure Canada Active Pharmaceutical Ingredients Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Active Pharmaceutical Ingredients Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Active Pharmaceutical Ingredients Revenue Growth Rate (2014-2019) (Million US$)
Table North America Active Pharmaceutical Ingredients Sales by Product (2014-2019) (K Units)
Table North America Active Pharmaceutical Ingredients Sales Market Share by Product (2014-2019)
Figure 2018 North America Active Pharmaceutical Ingredients Market Share by Product
Table North America Active Pharmaceutical Ingredients Sales by End User (2014-2019) (K Units)
Table North America Active Pharmaceutical Ingredients Sales Market Share by End User (2014-2019)
Figure 2018 North America Active Pharmaceutical Ingredients Market Share by End User
Figure Europe Active Pharmaceutical Ingredients Sales Growth Rate 2014-2019 (K Units)
Figure Europe Active Pharmaceutical Ingredients Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Active Pharmaceutical Ingredients Sales by Countries (2014-2019) (K Units)
Table Europe Active Pharmaceutical Ingredients Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Active Pharmaceutical Ingredients Sales Market Share by Countries
Table Europe Active Pharmaceutical Ingredients Revenue by Countries (2014-2019) (Million US$)
Table Europe Active Pharmaceutical Ingredients Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Active Pharmaceutical Ingredients Revenue Market Share by Countries
Figure Germany Active Pharmaceutical Ingredients Sales Growth Rate (2014-2019) (K Units)
Figure Germany Active Pharmaceutical Ingredients Revenue Growth Rate (2014-2019) (Million US$)
Figure France Active Pharmaceutical Ingredients Sales Growth Rate (2014-2019) (K Units)
Figure France Active Pharmaceutical Ingredients Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Active Pharmaceutical Ingredients Sales Growth Rate (2014-2019) (K Units)
Figure UK Active Pharmaceutical Ingredients Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Active Pharmaceutical Ingredients Sales Growth Rate (2014-2019) (K Units)
Figure Italy Active Pharmaceutical Ingredients Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Active Pharmaceutical Ingredients Sales Growth Rate (2014-2019) (K Units)
Figure Russia Active Pharmaceutical Ingredients Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Active Pharmaceutical Ingredients Sales by Product (2014-2019) (K Units)
Table Europe Active Pharmaceutical Ingredients Sales Market Share by Product (2014-2019)
Figure 2018 Europe Active Pharmaceutical Ingredients Market Share by Product
Table Europe Active Pharmaceutical Ingredients Sales by End User (2014-2019) (K Units)
Table Europe Active Pharmaceutical Ingredients Sales Market Share by End User (2014-2019)
Figure 2018 Europe Active Pharmaceutical Ingredients Market Share by End User
Figure Asia Pacific Active Pharmaceutical Ingredients Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Active Pharmaceutical Ingredients Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Active Pharmaceutical Ingredients Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Active Pharmaceutical Ingredients Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Active Pharmaceutical Ingredients Sales Market Share by Countries
Table Asia Pacific Active Pharmaceutical Ingredients Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Active Pharmaceutical Ingredients Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Active Pharmaceutical Ingredients Revenue Market Share by Countries
Figure China Active Pharmaceutical Ingredients Sales Growth Rate (2014-2019) (K Units)
Figure China Active Pharmaceutical Ingredients Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Active Pharmaceutical Ingredients Sales Growth Rate (2014-2019) (K Units)
Figure Japan Active Pharmaceutical Ingredients Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Active Pharmaceutical Ingredients Sales Growth Rate (2014-2019) (K Units)
Figure Korea Active Pharmaceutical Ingredients Revenue Growth Rate (2014-2019) (Million US$)
Figure India Active Pharmaceutical Ingredients Sales Growth Rate (2014-2019) (K Units)
Figure India Active Pharmaceutical Ingredients Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Active Pharmaceutical Ingredients Sales Growth Rate (2014-2019) (K Units)
Figure Australia Active Pharmaceutical Ingredients Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Active Pharmaceutical Ingredients Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Active Pharmaceutical Ingredients Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Active Pharmaceutical Ingredients Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Active Pharmaceutical Ingredients Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Active Pharmaceutical Ingredients Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Active Pharmaceutical Ingredients Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Active Pharmaceutical Ingredients Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Active Pharmaceutical Ingredients Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Active Pharmaceutical Ingredients Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Active Pharmaceutical Ingredients Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Active Pharmaceutical Ingredients Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Active Pharmaceutical Ingredients Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Active Pharmaceutical Ingredients Sales by Product (2014-2019) (K Units)
Table Asia Pacific Active Pharmaceutical Ingredients Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Active Pharmaceutical Ingredients Market Share by Product
Table Asia Pacific Active Pharmaceutical Ingredients Sales by End User (2014-2019) (K Units)
Table Asia Pacific Active Pharmaceutical Ingredients Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Active Pharmaceutical Ingredients Market Share by End User
Figure Central & South America Active Pharmaceutical Ingredients Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Active Pharmaceutical Ingredients Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Active Pharmaceutical Ingredients Sales by Countries (2014-2019) (K Units)
Table Central & South America Active Pharmaceutical Ingredients Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Active Pharmaceutical Ingredients Sales Market Share by Countries
Table Central & South America Active Pharmaceutical Ingredients Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Active Pharmaceutical Ingredients Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Active Pharmaceutical Ingredients Revenue Market Share by Countries
Figure Brazil Active Pharmaceutical Ingredients Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Active Pharmaceutical Ingredients Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Active Pharmaceutical Ingredients Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Active Pharmaceutical Ingredients Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Active Pharmaceutical Ingredients Sales by Product (2014-2019) (K Units)
Table Central & South America Active Pharmaceutical Ingredients Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Active Pharmaceutical Ingredients Market Share by Product
Table Central & South America Active Pharmaceutical Ingredients Sales by End User (2014-2019) (K Units)
Table Central & South America Active Pharmaceutical Ingredients Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Active Pharmaceutical Ingredients Market Share by End User
Figure Middle East and Africa Active Pharmaceutical Ingredients Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Active Pharmaceutical Ingredients Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Active Pharmaceutical Ingredients Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Active Pharmaceutical Ingredients Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Active Pharmaceutical Ingredients Sales Market Share by Countries
Table Middle East and Africa Active Pharmaceutical Ingredients Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Active Pharmaceutical Ingredients Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Active Pharmaceutical Ingredients Revenue Market Share by Countries
Figure GCC Countries Active Pharmaceutical Ingredients Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Active Pharmaceutical Ingredients Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Active Pharmaceutical Ingredients Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Active Pharmaceutical Ingredients Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Active Pharmaceutical Ingredients Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Active Pharmaceutical Ingredients Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Active Pharmaceutical Ingredients Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Active Pharmaceutical Ingredients Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Active Pharmaceutical Ingredients Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Active Pharmaceutical Ingredients Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Active Pharmaceutical Ingredients Market Share by Product
Table Middle East and Africa Active Pharmaceutical Ingredients Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Active Pharmaceutical Ingredients Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Active Pharmaceutical Ingredients Market Share by End User
Table Merck Company Details
Table Merck Active Pharmaceutical Ingredients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Recent Development
Table Novartis Company Details
Table Novartis Active Pharmaceutical Ingredients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Recent Development
Table Pfizer Company Details
Table Pfizer Active Pharmaceutical Ingredients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table Roche Company Details
Table Roche Active Pharmaceutical Ingredients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Roche Recent Development
Table Sun Pharmaceutical Industries Company Details
Table Sun Pharmaceutical Industries Active Pharmaceutical Ingredients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sun Pharmaceutical Industries Recent Development
Table Teva Pharmaceutical Industries Company Details
Table Teva Pharmaceutical Industries Active Pharmaceutical Ingredients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Teva Pharmaceutical Industries Recent Development
Table Abbott Laboratories Company Details
Table Abbott Laboratories Active Pharmaceutical Ingredients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Abbott Laboratories Recent Development
Table Emcure Pharmaceuticals Company Details
Table Emcure Pharmaceuticals Active Pharmaceutical Ingredients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Emcure Pharmaceuticals Recent Development
Table Ipca Laboratories Company Details
Table Ipca Laboratories Active Pharmaceutical Ingredients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Ipca Laboratories Recent Development
Table Johnson Matthey Company Details
Table Johnson Matthey Active Pharmaceutical Ingredients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Johnson Matthey Recent Development
Table Guilin Pharmaceutical Company Details
Table Johnson & Johnson Company Details
Table Lonza Group Company Details
Table Global Active Pharmaceutical Ingredients Sales Forecast by Regions 2019-2025 (K Units)
Table Global Active Pharmaceutical Ingredients Sales Market Share Forecast by Regions 2019-2025
Table Global Active Pharmaceutical Ingredients Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Active Pharmaceutical Ingredients Revenue Market Share Forecast by Regions 2019-2025
Table Global Active Pharmaceutical Ingredients Sales Forecast by Product 2019-2025 (K Units)
Table Global Active Pharmaceutical Ingredients Sales Market Share Forecast by Product 2019-2025
Table Global Active Pharmaceutical Ingredients Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Active Pharmaceutical Ingredients Revenue Market Share Forecast by Product 2019-2025
Table Global Active Pharmaceutical Ingredients Sales Forecast by End User 2019-2025 (K Units)
Table Global Active Pharmaceutical Ingredients Sales Market Share Forecast by End User 2019-2025
Figure North America Active Pharmaceutical Ingredients Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Active Pharmaceutical Ingredients Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Active Pharmaceutical Ingredients Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Active Pharmaceutical Ingredients Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Active Pharmaceutical Ingredients Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Active Pharmaceutical Ingredients Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Active Pharmaceutical Ingredients Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Active Pharmaceutical Ingredients Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Active Pharmaceutical Ingredients Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Active Pharmaceutical Ingredients Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Active Pharmaceutical Ingredients Value Chain
Table Active Pharmaceutical Ingredients Customers List
Table Active Pharmaceutical Ingredients Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
高効能のある有効成分（HPAPI）の世界市場：市場規模・現状・予測 The drugs are classified as High Potent if its Occupational Exposure Limit (OELs) = 10µg/m3.In 2018, the global High Potency Active Pharmaceutical Ingredients (HPAPI) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. Th…- 医薬品有効成分（API）の世界市場：市場規模・現状・予測 The Active Pharmaceutical Ingredient (API) is the part of any drug that produces its effects. Some drugs, such as combination therapies, have multiple active ingredients to treat different symptoms or act in different ways.In 2018, the global Active Pharmaceutical Ingredient (API) market size was xx…
- 世界の特殊成分市場：専門的調査 The global Specialty Ingredients market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Specialty Ingredients volume and value at global level, regional level and company level. From a global per…
- プロバイオティクス成分の世界市場：インサイト・予測 Probiotic substances contain live bacteria that are beneficial for human health.The increasing awareness about the benefits of probiotics to be one of the primary factors that will drive the growth of the probiotic ingredients market in the Americas in the coming years. The global Probiotic Ingredie…
- 世界のバイオテクノロジー成分市場：専門的調査 The global Biotech Ingredients market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Biotech Ingredients volume and value at global level, regional level and company level. From a global perspec…